This content has not been reviewed within the past year and may not represent Web MD's most up-to-date information. To find the most current information, please enter your topic of interest into our search box. " July 19, 2002 -- Chemotherapy may not be necessary for preventing some types of breast cancer from coming back in postmenopausal women. A new report shows treatment with the drug tamoxifen may be enough to prevent recurrence in these women, without the negative side effects that come with chemotherapy. women with breast cancers that have spread to the lymph nodes, the standard therapy includes a short course of chemotherapy followed by treatment with tamoxifen. But other experts say it's still too soon to consider withholding chemotherapy from women who have already suffered from breast cancer once, despite the potential side effects of chemotherapy. Although previous studies have shown that tamoxifen is effective at preventing tumors from coming back in women who have a type of breast cancer that grows when exposed to estrogen (known as estrogen-receptor or ER positive), researchers say there has been little evidence that chemotherapy provides any additional benefit for these women. The study, published in the July 17 issue of the Journal of the National Cancer Institute, involved 1,669 postmenopausal women who had undergone surgery to remove breast cancers that had not spread to the surrounding lymph nodes. To determine the impact of adding chemotherapy to tamoxifen use, the researchers randomly divided the women into two groups. Researchers say about half the women who had surgery for breast cancer between 19 in the U. One group received chemotherapy followed by tamoxifen and the other received tamoxifen alone for five years. side effect of tamoxifen is blood clots, including deep vein thrombosis (DVT) and pulmonary embolus. In some cases, health care professionals may use the trade name Nolvadex when referring to the generic drug name tamoxifen. This medication is classified as an "anti-estrogen." (For more detail, see "How this drug works" section below). You should seek emergency help and notify your health care provider immediately if you develop sudden chest pain and shortness of breath. Notify your health care provider within 24 hours if you notice that one leg is swollen, red, painful and/or warm to touch and the other is not. A side effect of tamoxifen can be the development of uterine cancer. Women who have not had a hysterectomy should have regular pap smears and gyn examinations. Abnormal vaginal bleeding should be reported to your health care provider. Propecia pregnancy Prednisone dosing instructions Buy flagyl overnight Antabuse tablet Sep 6, 2017. The most commonly used medicines to lower breast cancer risk are tamoxifen and raloxifene. Other medicines called aromatase inhibitors. Oct 19, 2017. As this could affect your ability to drive safely you should make sure you know how tamoxifen affects you before driving or operating machinery. Lerner LJ, Jordan VC. Development of antiestrogens and their use in breast cancer eighth Cain memorial award lecture. Cancer Res. 1990 Jul 15. Tamoxifen is a hormone therapy drug taken by many premenopausal women after completing their initial treatments for estrogen receptor positive breast cancer. To treat the side effects of tamoxifen (such as hot flashes) and to help with depression, doctors often prescribe antidepressants. Yet many antidepressants can interfere, or completely cancel out, the benefits of tamoxifen. Once a woman is finished with the primary treatment of breast cancer, with therapies such as surgery, chemotherapy, and radiation therapy, she may need to take tamoxifen. For women who have estrogen receptor positive tumors, hormone therapy can reduce the risk of the cancer coming back (recurrence) by around 50 percent. The choice of medication depends on menopausal status. If a woman is premenopausal, tamoxifen is usually the drug of choice. (For those who are postmenopausal, or who are premenopausal but have received ovarian suppression therapy, an aromatase inhibitor is usually used instead). Tamoxifen (Nolvadex®) is a medication in pill form that has been used for more than 25 years to treat breast cancer in women and men. Tamoxifen is one of the most common endocrine therapy drugs. It has been shown to decrease the chance of recurrence in some early-stage breast cancers and to prevent the development of cancer in the opposite breast. Tamoxifen can also slow or stop the growth of cancer cells present in the body. There are an estimated 29 million women at increased risk for breast cancer in this country, and tamoxifen may offer another alternative to watchful waiting or prophylactic (preventative) mastectomy. Tamoxifen is classified as a selective estrogen receptor modulator (SERM) and works as an anti-estrogen: While the hormone estrogen promotes the growth of breast cancer cells, tamoxifen works by blocking estrogen from attaching to estrogen receptors on these cells. By blocking the estrogen receptors, it is believed that the growth of the breast cancer cells will be halted. Is tamoxifen safe Antidepressants That Interact With Tamoxifen - Verywell Health, Tamoxifen important things to know - NetDoctor Is ciprofloxacin safe during pregnancyBrahmin.com register handbagViagra risksHerbal viagraBuy xenical for cheap Tamoxifen with the possible side effects, which can be quite. Tamoxifen as part of their treatment plan following a. Is Tamoxifen safe? What are the major. To Tamoxifen or not? - Breast Cancer Network Australia. How safe is tamoxifen? - NCBI - NIH. Tamoxifen in Pregnancy Safety Concerns - Verywell Health. Nov 29, 2016. Tamoxifen is the most prescribed drug in the world for people with hormone receptor positive breast cancer, purportedly for the ability of this. Dec 14, 2009. Apparently the answer is millions of women — people like Cindy Birkhold of Sarasota, Fla. The pill is tamoxifen, and Ms. Birkhold, now 52, was. Find information about tamoxifen, a medicine to treat breast cancer, from Cleveland Clinic, including side effects, precautions, concerns, and more.